학술논문
Re: Wells et al.: Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial (Ophthalmology 2016;123:1351-1359) REPLY
Document Type
Journal
Source
Subject
Language
English
ISSN
15494713